Fennec Pharmaceuticals Inc.FENCNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
35.89%
↓ 33% below average
Average (39q)
53.57%
Historical baseline
Range
High:2498.85%
Low:-661.54%
Volatility
5899.3%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 35.89% |
| Q2 2025 | 3.66% |
| Q1 2025 | 15.46% |
| Q4 2024 | 29.18% |
| Q3 2024 | -15.58% |
| Q2 2024 | -73.20% |
| Q1 2024 | 166.95% |
| Q4 2023 | 50.39% |
| Q3 2023 | 92.11% |
| Q2 2023 | 103.47% |
| Q1 2023 | 9.18% |
| Q4 2022 | 2498.85% |
| Q3 2022 | -661.54% |
| Q2 2022 | -11.94% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | -100.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |